Panju M, Raso D, Patel A, Panju A, Ginsberg J
Department of Medicine, McMaster University Medical Center, Hamilton, Ontario, Canada.
J R Coll Physicians Edinb. 2011 Dec;41(4):304-8. doi: 10.4997/JRCPE.2011.404.
Venous thromboembolism (VTE) prophylaxis is effective in the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in medical patients.
A retrospective chart review was performed on medical inpatients at two academic hospitals in Hamilton, Ontario to investigate if patients received VTE prophylaxis as per current guidelines.
An analysis was performed on 762 patient charts and 170 met inclusion criteria for use of pharmacological VTE prophylaxis. Of these, 91 (54%) received pharmacological VTE prophylaxis. In 63 patients with a contraindication to pharmacological VTE prophylaxis, 16 (25%) received non-pharmacological VTE prophylaxis.
The provision rate of pharmacological VTE prophylaxis in hospitalised medical patients who met pre-defined clinical criteria for prophylaxis was 54%. The rate of prophylaxis increased with additional VTE risk factors to a peak rate of 67%. There is room for the development of strategies to improve the use of VTE prophylaxis in hospitalised medical patients.
静脉血栓栓塞症(VTE)预防措施对于预防内科患者的深静脉血栓形成(DVT)和肺栓塞(PE)有效。
对安大略省汉密尔顿市两家学术医院的内科住院患者进行回顾性病历审查,以调查患者是否按照当前指南接受VTE预防措施。
对762份患者病历进行了分析,其中170例符合使用药物性VTE预防措施的纳入标准。在这些患者中,91例(54%)接受了药物性VTE预防措施。在63例有药物性VTE预防措施禁忌证的患者中,16例(25%)接受了非药物性VTE预防措施。
符合预先定义的预防临床标准的住院内科患者中,药物性VTE预防措施的提供率为54%。随着VTE风险因素的增加,预防率上升至峰值67%。在改善住院内科患者VTE预防措施的使用方面,仍有制定策略的空间。